BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhu F, Li YM, Feng TT, Wu Y, Zhang HX, Jin GY, Liu JP. Freeze-dried Si-Ni-San powder can ameliorate high fat diet-induced non-alcoholic fatty liver disease. World J Gastroenterol 2019; 25(24): 3056-3068 [PMID: 31293341 DOI: 10.3748/wjg.v25.i24.3056]
URL: https://www.wjgnet.com/1007-9327/full/v25/i24/3056.htm
Number Citing Articles
1
Qi Shao, Yiping Wu, Jing Ji, Tian Xu, Qiaoyu Yu, Chongyang Ma, Xuejing Liao, Fafeng Cheng, Xueqian Wang. Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver DiseaseFrontiers in Psychiatry 2021; 12 doi: 10.3389/fpsyt.2021.711835
2
Zhi-Tong Zhang, Wen-Jiao He, Si-Min Deng, Shu-Hong Xu, Xia Zeng, Zheng-Ming Qian, Zhi-Quan Chen, Shu-Mei Wang, Dan Tang. Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activationEuropean Journal of Pharmacology 2022; 933: 175291 doi: 10.1016/j.ejphar.2022.175291
3
Jian-Hong Ding, Zhe Jin, Xiao-Xu Yang, Jun Lou, Wei-Xi Shan, Yan-Xia Hu, Qian Du, Qiu-Shi Liao, Rui Xie, Jing-Yu Xu. Role of gut microbiota via the gut-liver-brain axis in digestive diseasesWorld Journal of Gastroenterology 2020; 26(40): 6141-6162 doi: 10.3748/wjg.v26.i40.6141
4
Tian Lan, Xiao-juan Geng, Si-jia Zhang, Xi-xi Zeng, Jun-jie Ying, Yi Xu, Shi-yu Liu, Ping Li, Yu-hua Tong, Wen Wang, Zhu-jun Mao, Si-wei Wang. Si-Ni-San inhibits hepatic Fasn expression and lipid accumulation in MAFLD mice through AMPK/p300/SREBP-1c axisPhytomedicine 2024; 123: 155209 doi: 10.1016/j.phymed.2023.155209
5
Xu Yang, Junqi Zhang, Yanghao Li, Huiting Hu, Xiang Li, Tonghui Ma, Bo Zhang. Si–Ni-San promotes liver regeneration by maintaining hepatic oxidative equilibrium and glucose/lipid metabolism homeostasisJournal of Ethnopharmacology 2024; 326: 117918 doi: 10.1016/j.jep.2024.117918
6
Anhui Wang, Xue Yang, Jiachun Lin, Yali Wang, Jinni Yang, Yuting Zhang, Yuan Tian, Haijuan Dong, Zunjian Zhang, Rui Song. Si-Ni-San alleviates intestinal and liver damage in ulcerative colitis mice by regulating cholesterol metabolismJournal of Ethnopharmacology 2025; 336: 118715 doi: 10.1016/j.jep.2024.118715
7
Kangning Zheng, Wenhan Zhou, Jingmin Ji, Yu Xue, Yiwei Liu, Caige Li, Zhiqin Zhang, Junlan Lu, Xinli Shi, Yongmin Li. Si-Ni-San reduces lipid droplet deposition associated with decreased YAP1 in metabolic dysfunction–associated fatty liver diseaseJournal of Ethnopharmacology 2023; 305: 116081 doi: 10.1016/j.jep.2022.116081
8
Min Liu, Wei Shi, Yefang Huang, Yeke Wu, Keming Wu. Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disordersFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1134430
9
Yuan Ma, Kewei Sun, Jianzhong Cao, Xiaowu Qin, Jiaoling Shi, Huiying Li, Jun Zhang, Tao Zhang. Acupuncture combined with Chinese herbal medicine on non-alcoholic fatty liver diseaseMedicine 2021; 100(51): e28083 doi: 10.1097/MD.0000000000028083
10
Longshan Ji, Qian Li, Yong He, Xin Zhang, Zhenhua Zhou, Yating Gao, Miao Fang, Zhuo Yu, Robim M. Rodrigues, Yueqiu Gao, Man Li. Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor BungeActa Pharmaceutica Sinica B 2022; 12(9): 3529 doi: 10.1016/j.apsb.2022.05.001
11
Ning Zhang, Tong Liu, Jianan Wang, Yingying Xiao, Ying Zhang, Jun Dai, Zhihong Ma, Donglai Ma. Si-Ni-San Reduces Hepatic Lipid Deposition in Rats with Metabolic Associated Fatty Liver Disease by AMPK/SIRT1 PathwayDrug Design, Development and Therapy 2023; : 3047 doi: 10.2147/DDDT.S417378
12
Xiaoyi Wei, Weixin Hou, Jiajun Liang, Peng Fang, Bo Dou, Zisong Wang, Jiayang Sai, Tian Xu, Chongyang Ma, Qiuyun Zhang, Fafeng Cheng, Xueqian Wang, Qingguo Wang. Network Pharmacology-Based Analysis on the Potential Biological Mechanisms of Sinisan Against Non-Alcoholic Fatty Liver DiseaseFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.693701
13
Hang Chu, Weitao Zhang, Yan Tan, Zhipeng Diao, Peng Li, Yapeng Wu, Like Xie, Jianguo Sun, Ke Yang, Pingping Li, Cen Xie, Ping Li, Qian Hua, Xiaojun Xu. Qing-Zhi-Tiao-Gan-Tang (QZTGT) prevents nonalcoholic steatohepatitis (NASH) by expression pattern correctionJournal of Ethnopharmacology 2023; 317: 116665 doi: 10.1016/j.jep.2023.116665
14
Yanwei LI, Yunrui LU, Mozuo NIAN, Qiuju SHENG, Chong ZHANG, Chao HAN, Xiaoguang DOU, Yang DING. Therapeutic potential and mechanism of Chinese herbal medicines in treating fibrotic liver diseaseChinese Journal of Natural Medicines 2023; 21(9): 643 doi: 10.1016/S1875-5364(23)60443-1
15
Qiong Wu, Fangsi Zhu, Yu Yao, Luyun Chen, Yijie Ding, Yong Su, Chaoliang Ge. Sini san regulates intestinal flora and short-chain fatty acids to ameliorate hepatocyte apoptosis and relieve CCl4-induced liver fibrosis in miceFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1408459
16
Jianchao Li, Kaiyi Wu, Ying Zhong, Jiangying Kuang, Nana Huang, Xin Guo, Hang Du, Chong Guo, Rongrong Li, Xiaomin Zhu, Tianyu Zhang, Liping Gong, Lisong Sheng, Rong Sun. Si–Ni-SAN ameliorates obesity through AKT/AMPK/HSL pathway-mediated lipolysis: Network pharmacology and experimental validationJournal of Ethnopharmacology 2023; 302: 115892 doi: 10.1016/j.jep.2022.115892
17
Shuwei Zhang, Yui-Tung Wong, Ka-Yu Tang, Hiu-Yee Kwan, Tao Su. Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern ScienceFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.572729
18
Qiwei Liu, Yunwen Xue, Jingjing Liu, Siqi Ren, Jie Xu, Jinni Yang, Yuanyue Xing, Zunjian Zhang, Rui Song. Saikosaponins and the deglycosylated metabolites exert liver meridian guiding effect through PXR/CYP3A4 inhibitionJournal of Ethnopharmacology 2021; 279: 114344 doi: 10.1016/j.jep.2021.114344
19
Yajie Cai, Xiaojiaoyang Li, Qi Han, Jinzhao Bai, Qi Zheng, Rong Sun, Runping Liu. Si–Ni-San improves experimental colitis by favoring Akkermensia colonizationJournal of Ethnopharmacology 2023; 305: 116067 doi: 10.1016/j.jep.2022.116067
20
Siliang Wang, Cheng Tang, Heng Zhao, Peiliang Shen, Chao Lin, Yun Zhu, Dan Han. Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver FibrosisFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.656115
21
Kai Yu, Kai Huang, Shisong Jiang, Xiao Tang, Xiuyun Huang, Linlin Sun, Linxing Pang, Cuiqin Mo. Protective function on liver and proteomic analysis of the improvement mechanism of Sedum sarmentosum Bunge extract on nonalcoholic fatty liver disease in Nile tilapiaAquaculture 2021; 531: 735977 doi: 10.1016/j.aquaculture.2020.735977
22
Xiaoying Xu, Huimei Hu, Haizhou Zeng, Boyi Li, Qiuxiong Yin, Yupeng Jiang, Linquan Zang, Changlin Zhao, Guoqiang Qian. Sinisan ameliorates colonic injury induced by water immersion restraint stress by enhancing intestinal barrier function and the gut microbiota structurePharmaceutical Biology 2023; 61(1): 598 doi: 10.1080/13880209.2023.2191643